Business Segments Shanghai Shyndec Pharmaceutical Co., Ltd.
Equities
600420
CNE000001JG2
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.610 CNY | -0.31% |
|
+0.21% | -4.85% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals Segment | 13.94B | 12.96B | 12.07B | 10.94B | 9.36B | |||||
Total Assets | 19.07B | 19.63B | 19.35B | 19.96B | 19.23B | |||||
Interest Expense | -110M | -107M | -57.88M | -36.89M | -4.39M | |||||
Income Tax Expense | 97.06M | 117M | 132M | 341M | 185M | |||||
CAPEX | -521M | -307M | -357M | -220M | -264M | |||||
EBT | 918M | 984M | 1.1B | 1.67B | 1.33B | |||||
D&A | 815M | 837M | 813M | 766M | 710M | |||||
Operating Income | 898M | 966M | 1.08B | 1.75B | 1.31B | |||||
Net Income | 568M | 628M | 692M | 1.08B | 942M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
East China | 3.69B | 3.68B | 3.17B | 2.81B | 2.34B | |||||
Overseas | 2.84B | 2.49B | 2.47B | 2.58B | 1.91B | |||||
Southern China | 1.57B | 1.2B | 1.28B | 1.11B | 1.27B | |||||
North China | 1.71B | 1.75B | 1.4B | 1.5B | 1.21B | |||||
Central China | 1.25B | 1.17B | 1.13B | 944M | 919M | |||||
South-West China | 1.47B | 1.48B | 1.26B | 1.08B | 876M | |||||
North-West China | 564M | 541M | 573M | 422M | 401M | |||||
North-East China | 669M | 502M | 514M | 397M | 398M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition